New prediction model estimates risk of opioid relapse early in treatment

A newly developed prediction model may be able to calculate the risk of opioid relapse among individuals in the early stages of medication treatment-;as early as three weeks into therapy.

MedPod Today: Big Medical Bill; GLP-1 Agonist Plateau; Grateful Patient Fundraising

The following is a transcript of the podcast episode: Rachael Robertson: Hey everybody. Welcome to MedPod Today, the podcast series where MedPage Today reporters share

September 30, 2023

Pharmalittle: We’re reading about rejection of an AbbVie Parkinson’s drug, PBM markups on mail order, and more

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After

June 26, 2024

Updated: BioMarin’s hemophilia A gene therapy Roctavian wins FDA approval after delay and rejection, priced at $2.9M

The FDA approved the first gene therapy to treat the genetic bleeding disorder hemophilia A on Thursday, capping a turbulent regulatory saga for BioMarin, which

June 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.